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Abstract
Tay-Sachs disease is a severe lysosomal disorder caused by mutations in the HexA gene coding for the a-subunit of
lysosomal b-hexosaminidase A, which converts GM2 to GM3 ganglioside. Hexa
2/2 mice, depleted of b-hexosaminidase A,
remain asymptomatic to 1 year of age, because they catabolise GM2 ganglioside via a lysosomal sialidase into glycolipid GA2,
which is further processed by b-hexosaminidase B to lactosyl-ceramide, thereby bypassing the b-hexosaminidase A defect.
Since this bypass is not effective in humans, infantile Tay-Sachs disease is fatal in the first years of life. Previously, we
identified a novel ganglioside metabolizing sialidase, Neu4, abundantly expressed in mouse brain neurons. Now we
demonstrate that mice with targeted disruption of both Neu4 and Hexa genes (Neu42/2;Hexa2/2) show epileptic seizures
with 40% penetrance correlating with polyspike discharges on the cortical electrodes of the electroencephalogram. Single
knockout Hexa2/2 or Neu42/2 siblings do not show such symptoms. Further, double-knockout but not single-knockout
mice have multiple degenerating neurons in the cortex and hippocampus and multiple layers of cortical neurons
accumulating GM2 ganglioside. Together, our data suggest that the Neu4 block exacerbates the disease in Hexa
2/2 mice,
indicating that Neu4 is a modifier gene in the mouse model of Tay-Sachs disease, reducing the disease severity through the
metabolic bypass. However, while disease severity in the double mutant is increased, it is not profound suggesting that
Neu4 is not the only sialidase contributing to the metabolic bypass in Hexa2/2 mice.
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Introduction
Tay-Sachs disease (reviewed in [1]) is the second most common
lysosomal storage disorder [2], especially frequent in two
populations: Ashkenazi Jews (carrier frequency 3.4%) [3] and
French Canadians from Gaspe´-Bas St-Laurent region of Quebec
(carrier frequency 5–7%) [4]. The disorder is caused by
mutations in the HexA gene coding for the a-subunit of lysosomal
b-hexosaminidase A (HexA), which removes N-acetyl-glucos-
amine residue from GM2 ganglioside, converting it to GM3
ganglioside. This causes accumulation of GM2 ganglioside in
neurons of affected patients with subsequent neuronal death,
resulting in progressive neurologic degeneration. Classic Tay-
Sachs disease is characterized by onset of muscle weakness and
hypotonia in infancy associated with myoclonic jerking upon
auditory stimulation, followed by spasticity, dementia, blindness
and epilepsy, with death in the second to fourth year of life [1].
Less frequent juvenile and adult forms of the disease are
characterized by later onset and milder symptoms [1]. The
clinically similar disorder, Sandhoff disease is caused by the
mutations in the HexB gene coding for the b-subunit of
hexosaminidase A which results in simultaneous deficiency of
Hex A and HexB [1].
Important insight into disease mechanism and the develop-
ment of therapies for Tay-Sachs disease have come from studying
the mouse model for the disorder, genetically targeted mice with
a disrupted Hexa gene. Independent publications from several
laboratories [5–7] reported that disruption of the Hexa gene in
mouse embryonic stem cells resulted in mice that showed no
neurologic abnormalities to one year of age, although they
exhibited biochemical and pathologic features of the disease [8].
In contrast, mice in which the Hexb gene was disrupted (a model
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of human Sandhoff disease) were severely affected by 2–3 months
of age and died 4–6 weeks later [5–6]. The phenotypic differences
between the two mouse models were explained by a major
difference in the ganglioside degradation pathways in humans
and mice. In particular, it was reported [5–6] that mouse neurons
are enriched in a lysosomal ganglioside sialidase activity that
removes the terminal sialic acid from GM2 ganglioside converting
it into glycolipid GA2 which is further degraded by HexB. Most
recent study in embryonic and postnatal brains and cultured
neural cells derived from Tay-Sachs and Sandhoff mouse models
shows that alternative roots for the formation of GM3 ganglioside
also exist in Hexb2/2 cells but they do not sufficiently reduce GM2
storage [9].
Recent studies from our laboratory suggested that lysosomal
sialidase/neuraminidase 4 (Neu4) may function as the ganglioside
sialidase acting in Hexa2/2 mice [10]. Neu4 previously cloned by
us [11] and other groups [12–14] is ubiquitously expressed in
human tissues and is active against all types of sialylated
glycoconjugates including oligosaccharides, glycoproteins and
gangliosides [11–14]. Our data showed that Neu4 in the presence
of detergents or lysosomal activator proteins actively desialylated
GM2 ganglioside [10]. In contrast, another lysosomal sialidase,
neuraminidase 1 (Neu1) had very little activity towards ganglio-
sides [10]. Genetically-targeted mice with knock-out of the Neu4
gene had lysosomal storage bodies in lung macrophages, spleen
macrophages and lymphocytes and showed increased levels of
gangliosides, ceramide, cholesterol and fatty acids in brain, liver,
lungs, and spleen [10]. Finally, we showed that transfection of
cultured neuroglia cells from a Tay-Sachs patient with a Neu4-
expressing plasmid restored normal morphological phenotype of
the cells and corrected the impaired metabolism of GM2
ganglioside via glycolipid GA2, thereby acting as a bypass for the
HexA deficiency [10].
In the current work, we assessed whether Neu4 is the enzyme
responsible in vivo for the metabolic bypass of the HexA defect in
the mouse model of Tay-Sachs disease by studying mice with a
double deficiency of Neu4 and HexA.
Results
Generation of HexA/Neu4-deficient mice
Mice with a combined deficiency of Neu4 sialidase and HexA
were obtained by intercrossing the previously described Neu4 and
Hexa knockout mouse models, both in C57BL/6NCrl genetic
backgrounds. Doubly homozygous Neu42/2;Hexa2/2 progeny
were viable and their genotypes were confirmed by PCR of tail
DNA (Figure S1). The absence of Neu4 transcripts in total mRNA
extracted from the brain of Neu42/2;Hexa2/2 mice was confirmed
by RT-PCR (Figure S2). HexA activity assayed using the HexA-
specific substrate, 4MU-b-D-N-acetylglucosamine sulfate, con-
firmed its complete deficiency (Figure S3). Acid sialidase activity,
assayed using 4MU-NeuAc as substrate, was significantly reduced
to ,30% activity, as anticipated (data not shown). Partial
reduction of acid sialidase activity reflects the presence of other
sialidases that contribute to the net sialidase activity against 4MU-
NeuAc [10]. Neu42/2;Hexa2/2 mice were born in the frequency
expected from Mendelian inheritance, indicating that simulta-
neous disruption of the Hexa and Neu4 genes does not cause
embryonic lethality. Up to the age of 3 months, Neu42/2;Hexa2/2
mice showed normal growth and were behaviorally and
physiologically indistinguishable from wild type animals. Both
males and females were fertile and could be bred to produce
knockout litters.
Seizure activity
Starting from 3 months of age Neu42/2;Hexa2/2 mice began to
show episodes of seizures provoked by handling of animals and
loud sounds (Video S1). The symptoms were observed in ,40% of
double-deficient animals (6 out of 14) but never in wild type mice
or in mice homozygous for the Neu4 or Hexa mutant alleles. One
mouse developed paralysis on the right hind limb (Figure S4).
Six animals, three Neu42/2;Hexa2/2 double mutants and three
Neu4+/+;Hexa2/2 single mutants, were implanted for video-
electroencephalogram (EEG) monitoring at the age of 16 weeks.
All three Neu42/2;Hexa2/2 mice exhibited generalized epileptic
seizures characterized clinically by myoclonic jerks. The EEG
during the seizures demonstrated polyspike discharges that always
involved the cortical contact (Figure 1A) and sometimes the
hippocampal contacts (not shown). Occasionally, discharges were
observed with no clinical accompaniment. EEG of all three Neu4+/+;
Hexa2/2mice were normal (Figure 1B).
Motor activity, behavioral changes and learning ability
At the age of 4 months, double mutants, single mutants and
wild-type mice performed equally well in the rotarod test,
indicating the absence of obvious motor deficits in mice with a
loss of Neu4 and Hexa (Figure S5). However, neurological
examination demonstrated that Neu42/2;Hexa2/2 mice showed
tremor during locomotion, wide based stance, and increased
spasticity in anterior and posterior limbs when held by the tail.
These abnormalities were not seen in wild type or single knockout
animals. At 4 months of age, all animals showed normal grid
walking. One month later, the Neu42/2;Hexa2/2 mice, but not the
single knockouts, demonstrated weakness on grid walking and
weakness on force test when placed on side of the cage.
The open field test was used at 4 months to measure behavioral
responses through exploratory behaviors which are altered by the
level of anxiety [15]. Rats and mice tend to avoid brightly
illuminated, novel, open spaces, so the open field environment acts
as an anxiogenic stimulus and allows the measurement of anxiety-
induced locomotor activity and exploratory behaviors. Although at
the first evaluation, double mutants tended to explore more than
Author Summary
Tay-Sachs disease is the second most common lysosomal
storage disorder, especially frequent in Ashkenazi Jews
and French Canadians. The disorder is caused by
mutations in the gene coding for lysosomal b-hexosamin-
idase A (HexA), resulting in accumulation of GM2 ganglio-
side in neurons followed by progressive neurologic
degeneration, fatal in early childhood. However mice,
depleted of HexA, remain asymptomatic to at least 1 year
of age, owing to the ability of these mice to catabolise
stored GM2 ganglioside via a lysosomal neuraminidase into
glycolipid GA2 further processed by b-hexosaminidase B,
thereby completely bypassing the HexA defect. Our
current study provides an explanation why the disease is
severe in humans but not in mice. We showed that mice
depleted of both HexA and ganglioside neuraminidase 4
(Neu4) show epileptic seizures similar to that often
observed in Tay-Sachs patients. Single HexA or Neu4
knockout mice do not show such symptoms. Further,
double-knockout but not single-knockout mice have
multiple degenerating cortical and hippocampal neurons
and multiple layers of cortical neurons accumulating GM2
ganglioside. Our data suggest that the Neu4 depletion
exacerbates the disease in HexA knockout mice, support-
ing the view that Neu4 is one of the modifier genes in the
mouse model of Tay-Sachs disease.
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the single mutants, this did not reach statistical significance. More
importantly, both groups showed a similar travel distance and
adaptation rate when compared at day 5 (Figure S6).
Finally to rule out any hippocampal dysfunction associated with
the spontaneous seizures, we performed the Morris Water Maze
test, a visuo-spatial task shown to be abnormal in animals with
spontaneous limbic seizures. Both Hexa2/2 and Neu42/2; Hexa2/2
mice at 4 months had no visual or motor deficit since they
reached the platform as rapidly as wild-type mice in the visible
platform pre-training test (not shown). All groups showed a
comparable learning curve with similar average escape latency to
reach the hidden platform (Days 4–8, Figure S7). When tested for
memory in the probe trial on day 8, both groups performed
similarly to wild type, although there was a tendency for the
Neu42/2;Hexa2/2 mice to spend less time and perform fewer
passes in the target quadrant (Figure S8).
Brain pathology
Microscopic examinations were performed on coronal and
sagittal paraffin-embedded sections of brain tissues. The study was
conducted in the following experimental groups: Neu42/2;Hexa2/2
mice, either showing or not showing epileptic crises; their
littermates with single deficiency of Neu4 (Neu42/2;Hexa+/+) or
Hex A (Neu4+/+;Hexa2/2); and wild type littermates used as
controls. For comparative purpose the study was conducted on
mice at the age of 6 months. The paraffin sections (5 mm thick)
Figure 1. Representative electroencephalography (EEG) recordings from double deficient Neu42/2;Hexa2/2 and single-deficient
Hexa2/2 mice. EEG of Neu42/2;Hexa2/2 mouse (A) shows simultaneously with a myoclonic jerk (indicated as ‘‘twitch’’ on the figure) high amplitude
polyspike discharges involving the cortical electrode with no diffusion to the underlying hippocampus. The EEG of Hexa2/2mouse (B) is normal. Inset
shows the enlargement of the myoclonic event. Each vertical line on the graph is 1 sec, voltage scale is 30 mV/mm.
doi:10.1371/journal.pgen.1001118.g001
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were stained with hematoxylin and eosin and viewed by light
microscopy. The examination of the tissues showed a normal
organization of the different cortical layers and hippocampal
neurons in all groups (not shown). At higher magnification a large
number of cortical neurons showed a vacuolated cytoplasm in the
Neu42/2;Hexa2/2mice, either with or without seizures, as well as in
their littermates with deficiency of Hex A only (Neu4+/+;Hexa2/2).
The brain sections of Neu42/2;Hexa+/+ and wild type mice did not
contain vacuolated neurons (not shown).
To study in detail the vacuolated neurons, we examined
coronal sections through the mid-region of brains obtained from
Neu42/2;Hexa2/2 mice, with or without seizures, as well as from
their wild type littermates and those with single deficiencies. Both
cortex and hippocampus were further trimmed into small
(,1 mm3) cubes and embedded in epon for pathological
examination. One mm thick sections of the brain tissues were
cut with an ultramicrotome and stained with toluidine blue. In all
brain epon sections of wild type mice, the cortical neurons were
normal (Figure 2A). In Neu4 deficient mice (Neu42/2;Hexa+/+),
cortical neurons were mostly normal except for few dark
degenerating neurons in deep layers of the cortex, possibly
corresponding to pyramidal cells (Figure 2B and Figure S9C). In
contrast, brains of mice with HexA deficiency only (Neu4+/+;
Hexa2/2) contained more degenerating neurons in the same deep
cortical layers (Figure 2C and Figure S9E). The superficial
neurons of the cortex were rarely affected. Brains of double
knockout (Neu42/2;Hexa2/2) mice without seizures also showed a
deep cortical layer of affected neurons but with higher frequency
then in the Neu4+/+;Hexa2/2 mice (Figure 2C and Figure S9G).
Double knockout mice with seizures showed multiple cortical
layers with even larger number of affected neurons (Figure 2D
and Figure S9I). High power images of affected neurons showed
that they contained an extensive accumulation of cytoplasmic
vacuoles stained by toluidine blue (Figure 2). Hippocampal
neurons exhibited a normal morphology in the brains of the wild
type mice, in mice with single Neu4+/+;Hexa2/2 and Neu42/2;
Hexa+/+ deficiencies, as well as in mice with double deficiency not
showing seizures, whereas hippocampal areas of mice with double
deficiency and seizures contained numerous neurons with an
extensive accumulation of cytoplasmic vacuoles stained by
toluidine blue (Figure S9). In order to quantify these pathological
changes, normal and affected neurons were counted in 6–9 epon
sections from similar randomly chosen cortical and hippocampal
regions of each mouse. The results showed that the number of
affected cortical and hippocampal neurons in the mice with
double deficiency of Neu4 and HexA (Neu42/2;Hexa2/2) with
seizures was significantly increased as compared to both single
HexA deficient (Neu4+/+;Hexa2/2) mice and double deficient
mice not showing seizures (Figure 3).
To further study the morphology of affected neurons ultrathin
sections from the mapped trimmed blocks containing the affected
neurons were stained with lead citrate and uranyl acetate and
observed under the electron microscope. For control purpose,
similar regions were mapped in wild type brains. High power
images showed that while normal neurons contained electron
dense lysosomes, the affected neurons contained large irregular
lysosomes presenting an accumulation of whorls of membranes
typical of lysosomal storage defects (Figure 4 and Figure S10).
Accumulation of GM2 ganglioside in the brain of Neu4
2/2;
Hexa2/2 mice
Bulk ganglioside composition of the brain tissues of 6 month-old
Neu42/2;Hexa2/2 mice, as well as of their wild type littermates
and those with single deficiencies of Neu4 or HexA were analyzed
by thin-layer chromatography (TLC). The ganglioside composi-
tion in the brain of Neu42/2;Hexa+/+ mice did not differ from that
of wild type animals with the exception of a previously reported
decrease of brain GM1 ganglioside [10], whereas Neu4
+/+;Hexa2/2
animals showed remarkable storage of GM2 ganglioside, also
consistent with previous reports [5,6] (Figure 5). Although we have
observed some variation in the content of different gangliosides
among different animals with the same genotype, on average
Neu42/2;Hexa2/2 mice showed a 2–3 fold higher ratio of GM2 to
GM1 ganglioside as compared to Neu4
+/+;Hexa2/2 animals
(Figure 5). This indicates that Neu4 is directly involved in
desialylation of GM2 ganglioside because otherwise the Neu4
deficiency would proportionally decrease levels of both GM1 and
GM2 gangliosides.
Accumulation of GM2 ganglioside in brain cells was further
studied by immunohistochemistry using the human-mouse chimeric
monoclonal antibody, KM966 [16]. This antibody has been shown
to be specific to GM2 ganglioside and is nonreactive toward
glycolipid GA2 also present in Neu4
+/+;Hexa2/2 mice, toward
globoside structurally similar to GM2 ganglioside, or toward GM3,
GD1a,b and GD2a,b gangliosides [16,17]. Analysis showed that GM2
ganglioside is undetectable in the brain of wild type or Neu42/2;
Hexa+/+ mice, but present in the brains of Neu4+/+;
Hexa2/2 mice, as well as in double knockout Neu42/2;Hexa2/2
mice (Figure 6A). In both genotypes ganglioside storage was
observed at low level in most areas of the brain, including the
hippocampus, but was more prominent in deep layers of the ventral
cortex (Figure 7A and 7B and Figures S11 and S12). Dual-labelling
studies showed that GM2-accumulating cells are recognized by the
NeuN antibody, indicating that they are neurons (Figure 7C). None
of them, however, are recognized by an antibody against
parvalbumin, a marker produced by about 50% of GABAergic
interneurons, raising the possibility that GM2-accumulating cells are
excitatory neurons (Figure S13).
In order to explore the relationship between GM2 ganglioside
accumulation and seizure activity, we next compared the number
of cells showing intense anti-GM2 antibody staining in the pyriform
region of Neu42/2;Hexa2/2 and Neu4+/+;Hexa2/2 mice
(Figure 6B). Neu42/2;Hexa2/2 mice with seizures showed a
significant increase of the number of GM2-storing cells (247610)
when compared with Neu42/2;Hexa2/2 mice without seizures
(14866) or with HexA deficient mouse (7765). Accumulation of
GM2 ganglioside in cortical neurons thus correlates with the
occurrence of seizure in Neu42/2;Hexa2/2 mice.
Discussion
Our study demonstrates that the Neu4 block exacerbates the
neurological phenotype the Hexa2/2 mouse, supporting the view
that Neu4 is a one of the modifier genes in the mouse model of Tay-
Sachs disease. Neu4/Hexa double homozygotes showed a more
severe disease than mice with either homozygous mutation alone.
Double mutant mice were healthy at birth but developed seizures
starting about 3 months of age, with EEG recordings showing typical
epileptic events consisting of myoclonic jerks associated with spike
wave discharges originating from the cortex and diffusing to the
hippocampus, while in Neu42/2 and Hexa2/2 mice seizures were
not observed until at least one year of age. Seizures were observed in
,40% of double-knockout mice which is consistent with a
penetrence rate observed for seizures in several mouse models of
Mendelian diseases [18,19]. Interestingly, the seizures observed in
double mutants were inducible by external stimuli such as handling
and noise, which is reminiscent of the startle myoclonia that can be
induced by noise in patients with Tay-Sachs disease. The
Neu4 as a Modifier Gene in Tay-Sachs Disease
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exaggerated startle response found in Tay-Sachs disease, however,
does not involve seizure activity but is likely explained by decreased
central inhibition. The fact that noise can trigger myoclonic seizures
in Neu42/2;Hexa2/2 mice suggests that decreased inhibition may
likewise be a feature of these mice. In addition, Neu42/2;Hexa2/2
mice, but not the single mutants, showed subtle early signs of motor
impairment, including tremor, weakness and spasticity, which can
also be found in Tay-Sachs patients.
The more severe neurological impairment of Neu42/2;Hexa2/2
mice correlated with increased accumulation of GM2 ganglioside.
This was confirmed by immunochemical analysis of their
brain tissues using anti-GM2 antibodies which showed that
double-knockout mice accumulate GM2 throughout the adult
brain but more prominently in the ventral cortex and
hippocampus. The number of GM2-positive cells was further
increased in double-knockout mice with epileptic seizures. A
Figure 2. Light microscopy of neurons in deep cortex of wild type mice, single Neu42/2 or Hexa2/2 knockouts and in double Neu42/2;
Hexa2/2 knockouts without and with seizures. Affected neurons containing vacuolated cytoplasm shown by arrows are present in Hexa2/2
knockouts (C) and in double knockouts without (D) and with (E) seizures, but absent in wild type mice (A) and single Neu42/2 knockouts (B).
Magnification61000. Panels represent typical images obtained for 3 mice for each genotype.
doi:10.1371/journal.pgen.1001118.g002
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similar correlation was observed between the severity of
phenotype and the number of affected cortical and hippocampal
neurons containing cytoplasmic vacuoles and storage bodies.
Electron micrographs of the affected neurons showed large
irregular lysosomes with characteristic membranous whorls
closely resembling the histopathological findings in human
Tay-Sachs patients. Interestingly the GM2-storing cells do not
express parvalbumin, which labels approximately 50% of
interneurons. Although we cannot exclude the possibility that
these cells correspond to smaller populations of interneurons, it
appears more likely that they are excitatory neurons. This latter
interpretation suggests that the seizures observed in the double
mutants are caused by the cortical lesions.
Our earlier in situ hybridization studies [10] indicated that
Neu4 is expressed in scattered cells that are distributed
throughout the adult brain, but with a greater density in the
ventral cortex. The identity of these Neu4-expressing cells
remains unknown. In the absence of Neu4 antibodies that are
amenable to immunohistochemistry, we have used a combination
of in situ hybridization and immunohistochemistry to show that
Neu4-expressing cells are not microglial as we previously
suggested [10] but now rule out or astrocytic cells (Figure S14).
However, attempts at determining whether these cells are neurons
failed because of the lack of neuron-specific antibodies that can
function in the context of our dual-labeling approach. Interest-
ingly, the number of GM2-accumulating cells in the ventral cortex
of the double mutants appeared greater than the number of
Neu4-expressing cells in the ventral cortex of wild type mice. This
discrepancy could be explained by the possibility that Neu4
influences GM2 accumulation in a non-cell autonomous fashion.
This hypothesis is consistent with our previous experiments
showing that the enzyme secreted from transfected cells
overexpressing Neu4 was taken up by neighbouring cells [11].
Alternatively, it is possible that Neu4 is expressed at lower levels
in a greater number of cells but that expression at this level was
not detectable by in situ hybridization.
If, however, Neu4 was the only sialidase contributing to the
bypass of the HexA defect in Hexa2/2 mice, then we would have
anticipated a phenotype matching the severity observed in
Hexb2/2 mice. Since Hexb2/2 mice lack both HexA and HexB,
both arms of the GM2 catabolizing pathway are blocked. These
mice show onset at 2–3 months of age with tremors, muscle
weakness, stiffening of the hind limbs and an ataxic gait [5–6].
The disease rapidly progresses to spastic quadriparesis, tremor,
myoclonus (startle and non-startle) and death by six weeks after
onset. In our study the development of epileptic seizures and the
accumulation of GM2 storage in adult Neu4
2/2;Hexa2/2 mice
demonstrates the predicted increased severity of disease indicative
of the importance of Neu4, but it is clear from the much milder
than expected phenotype that other sialidases also contribute to
the bypass. Two other sialidases, Neu1 and Neu3, are also
abundant in the mouse brain. Neu1 is a component of a
lysosomal multienzyme complex consisting of Neu1, a protective
protein/cathepsin A (PPCA) and b-galactosidase (reviewed in
[20]). Neu1 shows in vitro GM3 and GD1a ganglioside hydrolyzing
activity, but weak activity toward GM2 and is most active toward
sialyloligosaccharides and sialylglycoproteins [10,21]. Impaired
metabolism of GM3 ganglioside was observed in cultured skin
fibroblasts from patients with primary (sialidosis) or secondary
(galactosialidosis) sialidase deficiency [22] as well as a storage of
GM3 and GD3 gangliosides in visceral tissues but not in brain of
sialidosis patients [23]. Neu3 sialidase abundantly expressed in
mouse cerebellum [24] is present at the plasma membrane and
has also been described as facing inward on the membranes of
endosomes and lysosomes [25]. It shows high activity toward
majority of gangliosides including GM2 similar to that of Neu4
[10–11,14]. Further studies involving generation of genetically
targeted mice deficient in other neuraminidases and their
breeding with Hexa2/2 mouse are therefore necessary to
determine which of these enzymes contributes, along with
Neu4, to the bypass in Hexa2/2 mice.
Our mouse model with a double HexA/Neu4 deficiency prog-
resses toward the neuropathological abnormalities of Hexb2/2
mice or of human Tay-Sachs patients. While other sialidases
also may contribute to the bypass pathway, it is important to note
that transfection of Neu4 in cultured fibroblasts from patients
with sialidosis or galactosialidosis and of neuroglia cells from a
patient with Tay-Sachs disease resulted in increased sialidase
activity and normalization of lysosomal morphology [10,11].
Also, correction was observed in cells not receiving the targeting
vector, suggesting that secretion and reuptake of Neu4 might also
contribute to disease amelioration. Because Neu4 targets to the
lysosome, but does not require formation of a multienzyme
complex and appears to participate in secretion and reuptake by
nearby cells, it might act as an optimal pharmacologic modifier,
perhaps through pharmacologic induction, for the treatment of
human Tay-Sachs disease.
Materials and Methods
Animals
Generation of mice with targeted disruption of Neu4 and Hexa
genes has been previously described [6,10]. Both strains were
back-crossed for at least 5 generations to C57BL/6NCrl strain
distributed by Charles River Quebec. Homozygous animals from
each genotype were bred to each other and the litter genotyped by
PCR as previously described. Expression of the Neu4 and HexA
genes in mouse tissues was also analyzed by RT-PCR as described
below. The Neu4-deficient mice were compared with the
appropriate littermate controls. All mice were bred and main-
tained in the Canadian Council on Animal Care (CCAC)-
accredited animal facilities of the Ste-Justine Hospital Research
Center according to the CCAC guidelines. Mice were housed in
an enriched environment with continuous access to food and
water, under constant temperature and humidity, on a 12 h
light:dark cycle. Approval for the animal care and the use in the
experiments was granted by the Animal Care and Use Committee
of the Ste-Justine Hospital Research Center.
Figure 3. Percent of affected neurons in cortex and hippocam-
pus. Normal and affected (vacuolized) neurons were counted in 9 epon
sections from similar cortical and hippocampal regions of each mouse;
3 mice were studied for each genotype. * - significantly different from
Hexa2/2.
doi:10.1371/journal.pgen.1001118.g003
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Genotyping of mice
The genotypes of mice were determined using genomic DNA
extracted from the clipped tail tip. The PCR was performed in a
total volume of 50 ml containing 100 pmol of each primer,
0.2 mM dNTPs, 1.5 U taq polymerase (Invitrogen) and 100 ng
genomic DNA in 20 mM Tris (pH 7.4), 50 mM KCl, and
1.5 mM MgCl2. Multiplex primers for detection of Hexa alleles
were 59-GGCCAGATACAATCATACAG (Hexa-F), 59-CTGT-
CCACATACTCTC CCCACAT (Hexa-R), 59-CACCAAA-
GAAGGGAGCCGGT (PGK) and for the detection of Neu4
alleles were 59-CTCTTCTTCATTGCCGTGCT (Neu4F), 59-
GCCGAATATCATGGTGGAAA (Neu4R), 59-GACAAGGA-
GAGCCTC TGGTG (Neo). Samples were denatured for the
first cycle at 95uC for 5 min, followed by 35 cycles at 94uC for
Figure 4. Electron micrographs of mouse brain tissues. Cortical neurons from wild type (A) and Neu42/2 mice (B) show normal lysosomes.
Cortical neurons from Hexa2/2 (C) knockouts, and double (Neu42/2;Hexa2/2) knockouts without (D) and with seizures (E) show accumulation of
whorls of membranes in lysosomes characteristic of neurons of Tay-Sachs patients. Bars range between 1 and 2 mm. Panels represent typical images
obtained for 3 mice for each genotype.
doi:10.1371/journal.pgen.1001118.g004
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20 s, 57uC for 20 s and 72uC for 1 min, with a final extension
reaction at 72uC for 10 min. Similar PCR conditions were used
for Hexa and Neu4 allele genotyping.
Quantitative RT-PCR
Total RNA was isolated from cultured cells or mouse tissues
using the Trizol Reagent (Invitrogen) according to the manufac-
turer’s protocol and reverse-transcribed to cDNA by using random
primers and SuperScript III reverse transcriptase (Invitrogen).
Quantification of mouse Neu4 mRNA in cultured cells and mouse
tissues was performed using a LightCycler system (Roche,
Germany) and the following set of primers: 59-TGC AGT ACT
GGA GGA GCA CA-39 and 59-AGG TGT AAG CAG GAA
CAA GCA-39. b-Actin mRNA was used as a reference control.
Neurological examination of mice
The motor performance of mice was evaluated using a
simplified neurological examination as previously described
[26,27]. The evaluation was composed of the following tests:
activity (the normal mouse is placed in a clean cage with clean
bedding animals and must explore 3 sides of the cage within
1 min), locomotion (visual appreciation of locomotion, evaluation
of motor coordination i.e. normal linear progression, stance and
tremors), visual positioning (when placed approximately 10 cm
above a solid surface and lowered slowly toward the surface, the
capacity to symmetrically extend legs with a normal locomotor
pattern is evaluated), climbing (ability to climb up a gridded
surface with 1 cm squares) and force (ability to hang on the side of
the cage with 2 front legs when the mouse is placed in contact with
cage).
Monitoring for seizures
Electroencephalograms (EEGs) were performed in mice. A
stainless steel bipolar electrode (Plastics one, Roanoke, VA) was
chronically implanted, through a burr hole, into the right dorsal
hippocampus and overlying cortex. After a week recovery period,
EEGs were recorded for 2 hours per day for 4 to 5 days with the
Stellate Harmonie video-EEG system (Stellate, Montreal, Quebec,
Canada). Proper electrode placement within the target structures
was confirmed in all mice.
Rotating rod
The rotating rod motor coordination test was performed using
an accelerating Rota-rod treadmill for mice (3 cm diameter) to
assess for motor deficits. Animals were briefly trained before test at
4 rpm on a 5 line rota-rod unit. The animals were then tested
using an accelerated mode from 4 to 40 rpm over 5 minutes.
Three trials were performed, each separated by a 20 minute rest
period. The length of time that each animal was able to stay on the
rod was recorded.
Open field test
The open field test was performed to assess behavioural
disturbances associated with cortical dysfunction in mice [15].
The apparatus consisted of an arena of 40640 cm in surface area
and was surrounded from all sides by a 50 cm transparent wall. A
digital camera was mounted directly above the apparatus. The
images were transmitted to a PC running Any-maze tracking
system. Mice were gently placed in the center of the arena and
allowed to explore undisturbed for 15 minutes on the first day
(exploratory phase) and 3 days after habituation (habituation
phase). The observed parameters were indexed by traveled
distance recorded during 15 min and numbers of grooming and
rearing.
Morris Water Maze test
The mice were subjected to the Morris Water Maze test for
spatial learning [28] at the age of 4 months. Mice first received a 3-
day habituation period requiring them to swim (60 s) to a visible
platform located in a circular tank (1.4 m in diameter) filled with
Figure 5. Alteration of GM2 ganglioside catabolism in the brain tissues of Neu4
2/2;Hexa2/2 mice. Histograms show the ratio of GM2 and
GM1 gangliosides as measured by TLC in the extracts of brain tissues from wild-type (WT); Neu4
2/2,Hexa2/2 and Neu42/2;Hexa2/2 mice. Values
represent means 6 S.D. of duplicate measurements performed on 3–11 mice of 4–12 month of age. * p,0.001 as compared with the Hexa2/2 and
Neu42/2;Hexa2/2 animals by the two-tailed nonparametric t-test. Inset: Representative TLC images of orcinol-stained gangliosides from brain of the
WT, Neu42/2, Hexa2/2 and Neu42/2;Hexa2/2 mice at 12 months of age. Arrows indicate the positions of the ganglioside standards.
doi:10.1371/journal.pgen.1001118.g005
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Figure 6. Increased accumulation of GM2 ganglioside in brain neurons of double knockout Neu4
2/2; Hexa2/2 mice. (A) Typical images
of coronal sections from wild type (WT) mouse, mouse with HexA deficiency (Hexa2/2) and from double knockout mice without (Neu42/2;Hexa2/2)
and with episodes of seizures (Neu42/2;Hexa2/2 S) stained with anti-GM2 antibodies. H indicates hippocampus, C – cortex. Scale bar: 100 mm.
(B) Amount of neurons storing GM2-ganglioside in cortex from Neu4
2/2;Hexa2/2 mice with and without episodes of seizures and from a Hexa2/2
mice. The cells were counted in 10 sections from similar cortical regions of each mouse. Three mice were studied for each group. * - significantly
different from Hexa2/2.
doi:10.1371/journal.pgen.1001118.g006
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water made opaque with inert paint (2561uC). Then wall visual
cues and platform location were switched, the platform was
submerged (1 cm), and 5 days of hidden-platform trials ensued.
Two hours following hidden-platform testing, all mice were given a
probe trial (60 s) in which percentage time spent and distance
traveled in the target quadrant (no longer containing a platform)
were recorded, along with swim speed. In the hidden platform
testing, mice were given 5 trials of 90 s to find the platform
(maximum inter-trial interval of 45 min), being guided to and
allowed to stay on the platform for 5 s on the first day if they
exceeded the allotted time. Visual acuity and motivation were tested
during the habituation period. Escape latencies were acquired with
the 2020 Plus tracking system and Water 2020 software (Ganz
FC62D video camera; HVS Image, UK). Animals were allowed to
dry under a heating lamp after each trial to avoid hypothermia, and
all experiments were started at the same time every day. All
experiments were performed by the same investigator (VS).
In situ hybridization
Newborn brains were fixed in the Carnoy’s fluid, embedded in
paraffin and sectioned at 6 mM. Seven week-old mice were
anaesthetised and perfused via cardiac puncture with saline and
then 4% paraformaldehyde. Whole brains were rapidly removed,
post-fixed overnight and then processed to generate four sets of
20 mM adjacent coronal sections with a cryostat. In situ
hybridization was performed using radioactive probes as previ-
ously described [10] on one out of two sections of newborn brain
sets and selected adjacent sections from adult brains at an interval
of 150 mM. The Neu1 probe contained the entire 1.2 kb of mouse
cDNA. The Neu4 probes corresponding to a 1.1-kb sequence
fragments were generated by RT-PCR, using mouse newborn
total brain RNA extracts and the following set of primers: 59-AAG
CTT GAC TGG GCC ACC TTT GCT-39 and 59-CTG CAG
GCC AGC AAT GCC CCT GA-39. The RNA probes were
transcribed from linearized plasmids using either T7 or T3 RNA
polymerase in the presence of [35S]-UTP. Both sense and
antisense transcripts were used. After hybridization, slides were
dipped in the emulsion and exposed for a period of 2 weeks.
Immunohistochemistry
To prepare fixed tissues for immunohistochemical analysis,
transcardiac perfusion was initiated with phosphate–buffered
saline (pH 7.4) followed by 4% paraformaldehyde in phosphate-
saline buffer. Brain tissues were removed and placed in the same
Figure 7. Numerous neurons in ventral cortex of double knockout, epileptic mouse store GM2.ganglioside. This panel shows GM2
(green, right panels) and NeuN (red, middle panels) immunostaining in dorsal (A) and ventral (B) cortex in a double knockout, epileptic mouse. GM2
positive neurons (yellow, right panels) are much more numerous in ventral cortex compared to dorsal cortex. Scale bar: 100 mm. (C) High
magnification images showing GM2 (green, right panel) and NeuN (red, middle panel) immunostaining in layer 56 of ventral cortex in a double
knockout, epileptic mouse. NeuN staining is stronger in the perinuclear region and weaker in the cytoplasm of neuronal somata. Scale bar: 5 mm.
Panels represent typical images; 10 panels were studied.
doi:10.1371/journal.pgen.1001118.g007
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fixative overnight at 4uC, and then treated sequentially in 10%,
20% and 30% sucrose in 0.1 M sodium phosphate buffer (pH 7.2)
overnight at 4uC. The tissue blocks were embedded in OCT
compound before freezing at 280uC. Ten-twelve mm thick
sections were cut in cryostat and collected onto poly-lysine coated
slides. The slides were treated with 0.1% Triton X-100, blocked in
a humidified chamber with 5% goat serum, and KM966 antibody,
1:600 in 1XPBS, to detect GM2 ganglioside. The slides were
further incubated with DyLight 488-conjugated Affinipure Goat
anti-human IgG (Jackson immunoresearch laboratories) and
mounted with Cytoseal mounting medium. Slides were studied
on a Zeiss LSM510 inverted confocal microscope (Zeiss). Images
were processed and quantified using the LSM image browser
software (Zeiss) and Photoshop (Adobe).
Enzyme assays
Sialidase, b-glucosidase and b-hexosaminidase A activities in
cellular homogenates and in subcellular fractions from brain
tissues of Neu42/2 and wild type littermates mice were assayed
using the corresponding fluorogenic 4-methylumbelliferyl glyco-
side substrates as previously described [10]. Protein concentration
was determined using a Bio-Rad Bradford kit.
Light microscopy of mouse tissues
Knockout mice and their wild type littermates, 6 months of age,
were anesthetized with sodium pentobarbital and the brains fixed
by perfusion with 4% paraformaldehyde in phosphate-buffered
saline. After perfusion the brains were carefully removed, sliced by
a coronal section through the midregion, and immersed in the
same fixative for an additional 24 hrs. The tissues were
dehydrated in graded ethanol and embedded in paraffin. Paraffin
sections (5 mm thick) were deparaffinized in toluene, rehydrated
with ethanol (90%–50%) and stained with hematoxylin and eosin.
The sections were viewed and photographed in a Leica light
microscope.
Quantitative analysis of affected neurons in mouse brain
The cerebral cortex of mice from each group was subdivided
into superficial and deep regions. Adjacent superficial and deep
areas were photographed for manual counting of vacuolated
neurons by a non-biased observer blinded for the genotype of
mice. Nine epon sections for cortex and 9 sections for
hippocampus were analyzed for each mouse and 3 mice were
studied for each genotype.
Electron microscopy of mouse tissues
For electron microscopy evaluation knockout mice and their
wild type littermates, 6 months of age, were anesthetized with
sodium pentobarbital and the brains were perfused with 2.5%
glutaraldehyde in 5 mM phosphate, pH 7.5. The brains were
then carefully removed and a coronal section (2 mm thick)
containing the cortex and hippocampus was obtained using a
razor blade. The cortex and hippocampus were further trimmed
into small cubes and immersed in the same fixative for an
additional 24 hs. The tissues were dehydrated in graded ethanol
and propylene oxide and embedded in epon. Semi-thin sections
were cut and mounted on glass slides, stained with toluidine blue
and viewed by light microscopy. The regions of interest for
electron microscopy were selected and ultrathin sections were cut
and mounted on 200 mesh copper grids. Staining of the grids was
done with uranyl acetate for 5 min, followed by lead citrate for
2 min. The grids were viewed on a Tecnai FEI electron
microscope.
Measurement of gangliosides in mouse tissues
Lipids were extracted by adding 1 ml of a chloroform/methanol
mixture (1:1, v/v) to 250 mg aliquots of frozen brain tissue lysates
followed by homogenization using a Polytron PT3000 (Brinkman).
Phase separation was induced by adding 0.65 ml of phosphate-
buffered saline (PBS). After centrifugation at 500 g for 15 min, the
upper phase containing gangliosides was isolated. The lower phase
was washed first with PBS and then with water. The upper phases
were combined and passed through a Supelclean LC-18 column
(Supelco). Gangliosides were eluted first using methanol and then
the chloroform/methanol mixture. After evaporation under a
stream of nitrogen, the residue was resuspended in 0.1 ml of the
chloroform/methanol mixture and applied to a silica gel thin-layer
chromatography (TLC) plate that was developed using chloro-
form/methanol/0.22% CaCl2 (55:45:10, by vol.). After staining
with orcinol or resorcinol, gangliosides were identified by
comparing their Rf to those of authentic porcine brain ganglioside
standards (Avanti Polar Lipids).
Statistical analysis
Statistical analysis was performed using two-tailed t-test and
ANOVA test.
Supporting Information
Figure S1 Genotyping of Hexa-knockout and Neu4-
knockout mice by PCR analysis of tail genomic DNA.
(A) Hexa allele-specific PCR amplifying a 420 bp fragment in wild
type (+/+) mice, 420 and 210 bp fragments in heterozygous (+/2)
mutants and 210 bp fragment in homozygous (2/2) HexA-
deficient animals. (B) Neu4 allele-specific PCR amplifying a 465 bp
fragment in wild-type (+/+) mice, 465 and 635 bp fragments in
heterozygous (+/2) mutants and 635 bp fragment in homozygous
(2/2) Neu4-deficient animals.
Found at: doi:10.1371/journal.pgen.1001118.s001 (0.02 MB PDF)
Figure S2 Fold induction of four neuraminidase genes
(Neu1-Neu4) in adult brains of wild type, Neu42/2,
Hexa2/2 and Neu42/2;Hexa2/2 mice. No presence of
Neu4 transcripts was detected in the brains of Neu42/2 and
Neu42/2;HexA2/2 mice. Data show the means 6 SD of 2
independent experiments; brains of 3 mice were studied for each
genotype. Data were normalised to the level of b–actin and
expressed as fold increase as compared to the expression levels in
wild type mouse.
Found at: doi:10.1371/journal.pgen.1001118.s002 (0.01 MB PDF)
Figure S3 Confirmation of b-hexosaminidase A defi-
ciency in brain tissues from single knockout Hexa2/2
and double-knockout Neu42/2;Hexa2/2 mice. HexA
activity in total brain was measured against 4-metylumbelliferyl-
N-acetylglucosamine-6-sulfate (MUGS) substrate at pH 4.2 as
described in Phaneuf et al. (1996; HumMol Genet 5: 11–14). Data
represent the mean 6 SD of three independent experiments
performed on brains from 3 different mice for each genotype. * -
statistically different (p,0.05) from the WT group.
Found at: doi:10.1371/journal.pgen.1001118.s003 (0.01 MB PDF)
Figure S4 Paralysis on the right hind limb in the 4-
months old Neu42/2;Hexa2/2 mouse.
Found at: doi:10.1371/journal.pgen.1001118.s004 (0.03 MB PDF)
Figure S5 At the age of 4 months double-knockout
Neu42/2;Hexa2/2 mice show similar performance on
the rotarod test as single knockout Hexa2/2 mice. Graph
shows the means 6 SD. Six mice were studied for each genotype.
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Found at: doi:10.1371/journal.pgen.1001118.s005 (0.01 MB PDF)
Figure S6 At the age of 4 months both Hexa2/2 and
Neu42/2;Hexa2/2 mice showed a similar traveled
distance and adaptation rate in the open field test when
compared at day 5. Graph shows the means 6 SD. Six mice
were studied for each genotype.
Found at: doi:10.1371/journal.pgen.1001118.s006 (0.01 MB PDF)
Figure S7 Neither Hexa2/2 nor Neu42/2;Hexa2/2 mice
showed impaired performance in the spatial memory-
based Morris Water Maze test at 4 months. All mice
showed a similar average latency on day 1 of a hidden platform
test and a similar learning curve. Only the data from trials on days
4–8 that consisted of the hidden platform testing are shown.
Graph shows the means 6 SD. Six mice were studied for each
genotype.
Found at: doi:10.1371/journal.pgen.1001118.s007 (0.01 MB PDF)
Figure S8 During the removed-platform probe trial on
day 8, wild type, Hexa2/2 and Neu42/2;Hexa2/2 mice
displayed close time and traveling distance in the target
quadrant. Numbers of passes through the removed platform
were also similar. Swim speed was comparable among all groups.
Graph shows the means 6 SD. Six mice were studied for each
genotype.
Found at: doi:10.1371/journal.pgen.1001118.s008 (0.01 MB PDF)
Figure S9 Light microscopy of neurons in wild type
mice (WT), singe Neu42/2 or Hexa2/2 knockouts and in
double knockouts without (Neu42/2;Hexa2/2) and with
seizures (Neu42/2;Hexa2/2 S). Affected neurons containing
vacuolated cytoplasm are shown by arrows. H indicates
hippocampus, C – cortex. The panels show representative images
of at least 20 panels studied for 3 mice in each group.
Found at: doi:10.1371/journal.pgen.1001118.s009 (0.15 MB PDF)
Figure S10 Electron micrographs of hippocampal neu-
rons from wild type (A), single Neu42/2 (B) and Hexa2/2
(C) knockouts, and double (Neu42/2;Hexa2/2) knock-
outs without (D) and with seizures (E). Affected neurons
containing vacuolated cytoplasm are only present in B, C and D.
Bars range between 1 and 2 mm. The panels show representative
images of at least 20 panels studied for 3 mice in each group.
Found at: doi:10.1371/journal.pgen.1001118.s010 (0.34 MB PDF)
Figure S11 GM2 ganglioside is stored by sparse neurons
in CA1 region of the hippocampus of Neu42/2;Hexa2/2
mouse with seizures. (A) GM2 ganglioside (green, right panels)
and NeuN (red, middle panels) immunostaining in CA1 region of
the hippocampus in a Neu42/2;Hexa2/2 mouse with seizures.
NeuN staining is stronger in the perinuclear region of neuronal
somata. (B) High magnification images showing that GM2
ganglioside is stored by neurons in the pyramidal layer (arrows).
Scale bars: A, 50 mm; B, 20 mm. The panels show representative
images of at least 15 panels studied for 3 mice in each group.
Found at: doi:10.1371/journal.pgen.1001118.s011 (0.52 MB PDF)
Figure S12 GM2 ganglioside is stored by sparse neurons
in CA3 and dentate gyrus regions of the hippocampus of
double KO, epileptic mouse. Panels show GM2 ganglioside
(green, right panel) and NeuN (red, middle panels) immunostaining
in CA3 (A) and dentate gyrus (B) regions of the hippocampus in a
double Neu42/2;Hexa2/2 mouse with seizures. GM2 colocalizes
with NeuN (arrows). Scale bar: 100 mm. Panels show representative
images of at least 15 panels studied for 3 mice in each group.
Found at: doi:10.1371/journal.pgen.1001118.s012 (0.54 MB PDF)
Figure S13 GM2 ganglioside is not stored by parvalbu-
min-positive GABAergic interneurons in cortex of
Neu42/2;Hexa2/2 mouse with seizures. Panels show GM2
ganglioside (green, right panel) and NeuN (red, middle panels)
immunostaining in dorsal (A) and ventral (B) cortex in a Neu42/2;
Hexa2/2 mouse with seizures. Note that Parvalbumin-positive
neurons do not store GM2 (arrows). Parvalbumin is expressed by
about 50% of cortical GABAergic interneurons. Scale bar:
100 mm.
Found at: doi:10.1371/journal.pgen.1001118.s013 (0.39 MB PDF)
Figure S14 Neu4 is not expressed by astrocytes or
microglia cells. In situ hybridization with a Neu4 probe labels
few sparse cells in CA1 region of the hippocampus (arrows, left
and right panels). These cells are negative for immunostaining for
the astrocyte marker GFAP (A, green, middle panel) and
microglial marker Eba1a (B, red, middle panel) Scale bar:
20 mm. The panels show representative images of at least 10
panels studied.
Found at: doi:10.1371/journal.pgen.1001118.s014 (0.36 MB PDF)
Video S1
Found at: doi:10.1371/journal.pgen.1001118.s015 (4.73 MB
WMV)
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